A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

BONE MARROW TRANSPLANTATION

Volume 57, Issue 2, Pages 295-298

SPRINGERNATURE

-

Biophysics Oncology Hematology Immunology Transplantation

1. Public Health Service from the National Cancer Institute (NCI) [U24CA076518]
2. Public Health Service from the National Heart, Lung and Blood Institute (NHLBI) [U24CA076518]
3. Public Health Service from the National Institute of Allergy and Infectious Diseases (NIAID) [U24CA076518]
4. Health Resources and Services Administration (HRSA) [HHSH250201700006C]
5. Office of Naval Research [N00014-20-1-2705, N00014-20-1-2832]
6. Be the Match Foundation
7. Medical College of Wisconsin
8. National Marrow Donor Program
9. AbbVie
10. Actinium Pharmaceuticals, Inc.
11. Adaptive Biotechnologies Corporation
12. Adienne SA
13. Allovir, Inc.
14. Amgen, Inc.
15. Angiocrine Bioscience
16. Astellas Pharma US
17. Bluebird Bio, Inc.
18. Bristol Myers Squibb Co.
19. CSL Behring
20. CytoSen Therapeutics, Inc.
21. Daiichi Sankyo Co., Ltd.
22. Eurofins Viracor
23. ExcellThera
24. Fate Therapeutics
25. Gamida-Cell, Ltd.
26. Genentech Inc
27. GlaxoSmithKline
28. Incyte Corporation
29. Janssen/Johnson Johnson
30. Jasper Therapeutics
31. Jazz Pharmaceuticals, Inc.
32. Karyopharm Therapeutics
33. Kiadis Pharma
34. Kite, a Gilead Company
35. Kyowa Kirin
36. Legend Biotech
37. Magenta Therapeutics
38. Medac GmbH
39. Merck Co.
40. Millennium, the Takeda Oncology Co.
41. Miltenyi Biotec, Inc.
42. MorphoSys
43. Novartis Pharmaceuticals Corporation
44. Omeros Corporation
45. Oncoimmune, Inc.
46. Orca Biosystems, Inc.
47. Pfizer, Inc.
48. Pharmacyclics, LLC
49. Sanofi Genzyme
50. Seagen, Inc.
51. Stemcyte
52. Takeda Pharmaceuticals
53. Tscan
54. Vertex
55. Vor Biopharma
56. Xenikos BV
57. [K23 HL141445]